UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 226

Sortiert nach

C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study

Gut, 2008-11, Vol.57 (11), p.1518-1523

2008

Link zum Volltext

Verfügbarkeit prüfen

Cytokine Levels After Consumption of a Medicinal Agaricus blazei Murill‐Based Mushroom Extract, AndoSan™, in Patients with Crohn's Disease and Ulcerative Colitis in a Randomized Single‐Blinded Placebo‐Controlled Study

Scandinavian journal of immunology, 2016-12, Vol.84 (6), p.323-331

2016

Link zum Volltext

Verfügbarkeit prüfen

Effect of an Extract Based on the Medicinal Mushroom Agaricus blazei Murill on Expression of Cytokines and Calprotectin in Patients with Ulcerative Colitis and Crohn's disease

Scandinavian journal of immunology, 2011, Vol.73 (1), p.66-75

2011

Link zum Volltext

Verfügbarkeit prüfen

Health-related quality of life in patients with inflammatory bowel disease five years after the initial diagnosis

Scandinavian journal of gastroenterology, 2004-04, Vol.39 (4), p.365-373

2004

Link zum Volltext

Verfügbarkeit prüfen

Inflammatory bowel disease: re-evaluation of the diagnosis in a prospective population based study in south eastern Norway

Gut, 1997-03, Vol.40 (3), p.328-332

1997

Link zum Volltext

Verfügbarkeit prüfen

Increased skewing of X chromosome inactivation with age in both blood and buccal cells

Cytogenetic and genome research, 2007-01, Vol.116 (1-2), p.24-28

2007

Link zum Volltext

Verfügbarkeit prüfen

Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study

Gut, 2013-03, Vol.62 (3), p.368-375

2013

Link zum Volltext

Verfügbarkeit prüfen

Clinical Course during the 1st Year after Diagnosis in Ulcerative Colitis and Crohn's Disease: Results of a Large, Prospective Population-based Study in Southeastern Norway, 1990-93

Scandinavian journal of gastroenterology, 1997, Vol.32 (10), p.1005-1012

1997

Link zum Volltext

Verfügbarkeit prüfen

Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV)

BMC infectious diseases, 2019-11, Vol.19 (1), p.943-9, Article 943

2019

Link zum Volltext

Verfügbarkeit prüfen

Risk matrix model for prediction of colectomy in a population-based study of ulcerative colitis patients (the IBSEN study)

Scandinavian journal of gastroenterology, 2015-12, Vol.50 (12), p.1456-1462

2015

Link zum Volltext

Verfügbarkeit prüfen

Incidence of Ulcerative Colitis and Indeterminate Colitis in Four Counties of Southeastern Norway, 1990-93 A Prospective Population-Based Study

Scandinavian journal of gastroenterology, 1996, Vol.31 (4), p.362-366

1996

Link zum Volltext

Verfügbarkeit prüfen

Incidence of Crohn's Disease in Four Counties in Southeastern Norway, 1990-93 A Prospective Population-Based Study

Scandinavian journal of gastroenterology, 1996, Vol.31 (4), p.355-361

1996

Link zum Volltext

Verfügbarkeit prüfen

Bowel MR imaging with oral Gastrografin: an experimental study with healthy volunteers

European radiology, 2003-01, Vol.13 (1), p.100-106

2003

Link zum Volltext

Verfügbarkeit prüfen

Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial

BMJ (British Medical Journal), 2009-05, Vol.338 (7707), p.b1846-1366

2009

Link zum Volltext

Verfügbarkeit prüfen

Anaemia in inflammatory bowel disease: a population‐based 10‐year follow‐up

Alimentary pharmacology & therapeutics, 2014-01, Vol.39 (1), p.69-76

2014

Link zum Volltext

Verfügbarkeit prüfen

Development and Evaluation of Written Patient Information for Endoscopic Procedures

Endoscopy, 1997-01, Vol.29 (1), p.23-26

1997

Link zum Volltext

Verfügbarkeit prüfen

Cytokine Levels After Consumption of a Medicinal Agaricus blazei Murill-Based Mushroom Extract, AndoSan super((TM)), in Patients with Crohn's Disease and Ulcerative Colitis in a Randomized Single-Blinded Placebo-Controlled Study

Scandinavian journal of immunology, 2016-12, Vol.84 (6), p.323-331

2016

Link zum Volltext

Verfügbarkeit prüfen

Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway

Substance abuse treatment, prevention and policy, 2021-02, Vol.16 (1), p.20-10, Article 20

2021

Link zum Volltext

Verfügbarkeit prüfen

The Association Between Water Supply and Inflammatory Bowel Disease Based on a 1990–1993 Cohort Study in Southeastern Norway

American journal of epidemiology, 2008-11, Vol.168 (9), p.1065-1072

2008

Link zum Volltext

Verfügbarkeit prüfen

Peer involvement and cross-sector efforts in establishing integrated treatment of hepatitis C virus infection for people with substance use disorders: experiences from Norway

Substance abuse treatment, prevention and policy, 2019-12, Vol.14 (1), p.58-7, Article 58

2019

Link zum Volltext

Verfügbarkeit prüfen

Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016-2020

Substance abuse treatment, prevention and policy, 2020-12, Vol.15 (1), p.93-11, Article 93

2020

Link zum Volltext

Verfügbarkeit prüfen

Octreotide in patients with active ulcerative colitis treated with high dose corticosteroids (OPUS 1)

European journal of gastroenterology & hepatology, 2002-03, Vol.14 (3), p.243-248

2002

Link zum Volltext

Verfügbarkeit prüfen

Circulating levels of HMGB1 are correlated strongly with MD2 in HIV-infection: Possible implication for TLR4-signalling and chronic immune activation

Innate immunity (London, England), 2013-06, Vol.19 (3), p.290-297

2013

Link zum Volltext

Verfügbarkeit prüfen

Continuous Therapy With Certolizumab Pegol Maintains Remission of Patients With Crohn's Disease for up to 18 Months

Clinical gastroenterology and hepatology, 2010-07, Vol.8 (7), p.600-609

2010

Link zum Volltext

Verfügbarkeit prüfen

Intestinal IgA- and IgM-producing cells are not decreased in marathon runners

International journal of sports medicine, 1998-08, Vol.19 (6), p.425-431

1998

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 226

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(202)
Mit Volltextzugriff
(188)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(138)
Life Sciences & Biomedicine
(123)
Humans
(117)
Male
(89)
Adult
(76)
Female
(76)
Middle Aged
(59)
Biological And Medical Sciences
(52)
Medical Sciences
(42)
Gastroenterology & Hepatology
(41)
Aged
(39)
Adolescent
(25)
Animals
(25)
Aged, 80 And Over
(19)
Crohn's Disease
(19)
Gastroenterology. Liver. Pancreas. Abdomen
(18)
Other Diseases. Semiology
(18)
Stomach. Duodenum. Small Intestine. Colon. Rectum. Anus
(18)
Young Adult
(18)
Prospective Studies
(17)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study

Cytokine Levels After Consumption of a Medicinal Agaricus blazei Murill‐Based Mushroom Extract, AndoSan™, in Patients with Crohn's Disease and Ulcerative Colitis in a Randomized Single‐Blinded Placebo‐Controlled Study

Effect of an Extract Based on the Medicinal Mushroom Agaricus blazei Murill on Expression of Cytokines and Calprotectin in Patients with Ulcerative Colitis and Crohn's disease

Health-related quality of life in patients with inflammatory bowel disease five years after the initial diagnosis

Inflammatory bowel disease: re-evaluation of the diagnosis in a prospective population based study in south eastern Norway

Increased skewing of X chromosome inactivation with age in both blood and buccal cells

Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study

Clinical Course during the 1st Year after Diagnosis in Ulcerative Colitis and Crohn's Disease: Results of a Large, Prospective Population-based Study in Southeastern Norway, 1990-93

Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV)

Risk matrix model for prediction of colectomy in a population-based study of ulcerative colitis patients (the IBSEN study)

Incidence of Ulcerative Colitis and Indeterminate Colitis in Four Counties of Southeastern Norway, 1990-93 A Prospective Population-Based Study

Incidence of Crohn's Disease in Four Counties in Southeastern Norway, 1990-93 A Prospective Population-Based Study

Bowel MR imaging with oral Gastrografin: an experimental study with healthy volunteers

Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial

Anaemia in inflammatory bowel disease: a population‐based 10‐year follow‐up

Development and Evaluation of Written Patient Information for Endoscopic Procedures

Cytokine Levels After Consumption of a Medicinal Agaricus blazei Murill-Based Mushroom Extract, AndoSan super((TM)), in Patients with Crohn's Disease and Ulcerative Colitis in a Randomized Single-Blinded Placebo-Controlled Study

Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway

The Association Between Water Supply and Inflammatory Bowel Disease Based on a 1990–1993 Cohort Study in Southeastern Norway

Peer involvement and cross-sector efforts in establishing integrated treatment of hepatitis C virus infection for people with substance use disorders: experiences from Norway

Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016-2020

Octreotide in patients with active ulcerative colitis treated with high dose corticosteroids (OPUS 1)

Circulating levels of HMGB1 are correlated strongly with MD2 in HIV-infection: Possible implication for TLR4-signalling and chronic immune activation

Continuous Therapy With Certolizumab Pegol Maintains Remission of Patients With Crohn's Disease for up to 18 Months

Intestinal IgA- and IgM-producing cells are not decreased in marathon runners

Suchergebnisse filtern